INS and type 1 diabetes mellitus: The DCCT/EDIC study demonstrated the benefits of intensified insulin treatment and strict glycaemic control in T1D patients with a disease duration of 1–15 years, with regards to limiting the risk of vascular complications after a follow-up period of more than 12 years [64,65].